HPS Pharmacies wish to give notice that GlaxoSmithKline Australia are experiencing a supply interruption for Priorix® and Priorix-Tetra® as follows:
Measles, mumps and rubella vaccine
Measles, mumps, rubella and varicella vaccine
This supply interruption is due to increased demand following provision of the vaccine to measles outbreak control programs throughout Australia. Supplies of Priorix® to non-government customers are expected to return to normal in early October 2019. This supply interruption does not affect the supply of Priorix® under the National Immunisation Program (NIP). Supplies of Priorix-Tetra® are expected to return to normal by late October 2019. An alternative measles, mumps, rubella and varicella vaccine will be available for children under the NIP during this time.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact GlaxoSmithKline Australia on (03) 9413 7200 or your pharmacist at HPS Pharmacies.